3rd Annual MarketsandMarkets Next-Gen Immuno-Oncology Congress - VIRTUAL EVENT

June 25-26, 2020
CONFERENCE SPEAKERS
Advisors
Rakesh Dixit
Rakesh Dixit
CEO,
Bionavigen


Rakesh Dixit is a President & CEO, BIONAVIGEN, LLC, a biopharmaceutical virtual drug development company specializing in advising and consulting for all aspects of drug development, including discovery, preclinical development, CMC, translational sciences, clinical development and regulatory filing. Accomplished executive, inventor, and scientist with over 30 years of success with top biotechnology and pharmaceutical companies, including Merck, Johnson & Johnson, Medimmune, AstraZeneca.


Roy Baynes
Roy Baynes
Senior Vice President,
Merck


Roy Baynes is Senior Vice President Global Clinical Development and Chief Medical Officer at Merck Research Laboratories in Rahway, New Jersey. He was previously Senior Vice President of Oncology, Inflammation and Respiratory Therapeutics at Gilead Sciences and prior to that was Vice President Global Clinical Development and Therapeutic Area (TA) Head for Hematology / Oncology, at Amgen Inc. In the early years of his tenure at Amgen before becoming TA head of Hematology / Oncology in Clinical Development he was TA head for Hematology / Oncology in Global Medical Affairs. He graduated as a Medical Doctor and obtained a Master of Medicine and Doctor of Philosophy from the University of the Witwatersrand, Johannesburg, South Africa. He has had a long and distinguished career in the haematology-oncology-and stem cell transplantation fields, including drug development, basic research, clinical practice, clinical research, teaching and administration. He is a member of many international societies, including the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO), and has authored some 150 publications. He has been recurrently named among America’s top physicians. Before joining Amgen in 2002, he was the Charles Martin Professor of Cancer Research at the Barbara Ann Karmanos Cancer Institute, an NCI designated Comprehensive Cancer Center, at Wayne State University, Detroit, Michigan, USA.


Darrell Borger
Darrell Borger
Associate Director, Translational Sciences, ODDU,
Takeda



Mithun Khattar
Mithun Khattar
Immuno-Oncology Lead,
Takeda Oncology



Speakers
Shailendra Singh (Shelly)
Shailendra Singh (Shelly)
Chief Operating Officer,
MarketsandMarkets


Shailendra Singh (Shelly) is Chief Operating Officer of MnM and a member of its board. He focuses on global sales and client services functions, as well as commercial optimization at MarketsandMarkets. He has years of expe¬rience in global delivery and outsourcing sector in the IT/ Consulting/Analytics/Big Data sectors. Prior to MnM, he was leading the global sales, client services and commercial ef¬fectiveness functions for Mu Sigma, a unicorn company and a leading global provider of Decision Sciences and Big Data analytics solutions.


Rakesh Dixit
Rakesh Dixit
CEO,
Bionavigen


Rakesh Dixit is a President & CEO, BIONAVIGEN, LLC, a biopharmaceutical virtual drug development company specializing in advising and consulting for all aspects of drug development, including discovery, preclinical development, CMC, translational sciences, clinical development and regulatory filing. Accomplished executive, inventor, and scientist with over 30 years of success with top biotechnology and pharmaceutical companies, including Merck, Johnson & Johnson, Medimmune, AstraZeneca.


Roy Baynes
Roy Baynes
Senior Vice President,
Merck


Roy Baynes is Senior Vice President Global Clinical Development and Chief Medical Officer at Merck Research Laboratories in Rahway, New Jersey. He was previously Senior Vice President of Oncology, Inflammation and Respiratory Therapeutics at Gilead Sciences and prior to that was Vice President Global Clinical Development and Therapeutic Area (TA) Head for Hematology / Oncology, at Amgen Inc. In the early years of his tenure at Amgen before becoming TA head of Hematology / Oncology in Clinical Development he was TA head for Hematology / Oncology in Global Medical Affairs. He graduated as a Medical Doctor and obtained a Master of Medicine and Doctor of Philosophy from the University of the Witwatersrand, Johannesburg, South Africa. He has had a long and distinguished career in the haematology-oncology-and stem cell transplantation fields, including drug development, basic research, clinical practice, clinical research, teaching and administration. He is a member of many international societies, including the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO), and has authored some 150 publications. He has been recurrently named among America’s top physicians. Before joining Amgen in 2002, he was the Charles Martin Professor of Cancer Research at the Barbara Ann Karmanos Cancer Institute, an NCI designated Comprehensive Cancer Center, at Wayne State University, Detroit, Michigan, USA.


Stefan Gluck
Stefan Gluck
Vice President,
Celgene, USA



Dave Wustrow
Dave Wustrow
Senior VP Discovery and Preclinical Development,
RAPT Therapeutics



Darrell Borger
Darrell Borger
Associate Director, Translational Sciences, ODDU,
Takeda



Robert Petit
Robert Petit
Chief Scientific Officer,
Carisma Therapeutics



Nuzhat Pathan
Nuzhat Pathan
Director, Early Development, Translational and Immuno-Oncology,
Pfizer



Philip Arlen
Philip Arlen
Chief Scientific Officer, Senior Vice President,
Diverse Biotech



Nathaniel Wang
Nathaniel Wang
Oncology Vaccines Project Leader,
Janssen, Pharmaceutical Companies of Johnson and Johnson



Shailesh Maingi
Shailesh Maingi
Founder and CEO,
Kineticos Life Sciences



Soldano Ferrone
Soldano Ferrone
Professor of Surgery,
Harvard University, USA



Mithun Khattar
Mithun Khattar
Immuno-Oncology Lead,
Takeda Oncology



Marit van Buuren
Marit van Buuren
Director, T cell Immunology,
Neon Therapeutics



Robert Loberg
Robert Loberg
Executive Director,
Amgen



Raymond Perez
Raymond Perez
Program Leader, Early Clinical Development, Oncology,
Bristol-Myers Squibb



Adam J. Adler
Adam J. Adler
Professor of Immunology, Associate Director, Graduate Program in Immunology,
UCONN health



H. Toni Jun
H. Toni Jun
Senior Director, Preclinical Biology,
Lassen Therapeutics



Shilpa Alekar
Shilpa Alekar
Senior Medical Director, Clinical Development, Immuno-Oncology,
Pfizer



Matthew Morrow
Matthew Morrow
Senior Director, Immunoloy and Biomarkers,
Inovio Pharmaceuticals Inc.



Adil Daud
Adil Daud
Clinical Professor ,
UCSF